In chronic obstructive pulmonary disease (COPD), exacerbations (ECOPD), characterized
by an acute deterioration in respiratory symptoms, are fundamental events impacting …

Chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD)
frequently occur together and their coexistence is associated with worse outcomes than …

Severe exacerbations of COPD, ie, those leading to hospitalization, have profound clinical
implications for patients and significant economic consequences for society. The prevalence …

Chronic obstructive pulmonary disease (COPD) is a global health issue with high social and
economic costs. Concomitant chronic cardiac disorders are frequent in patients with COPD …

Background Observational studies suggest that beta-blockers may reduce the risk of
exacerbations and death in patients with moderate or severe chronic obstructive pulmonary …

The role of β-adrenoceptor antagonists (β-blockers) in cardiovascular therapy has been
subject to diverse trends and changes over the decades. With the advent of a wide variety of …

The Genetic Epidemiology of COPD (COPDGene) study is a noninterventional, multicenter,
longitudinal analysis of> 10,000 subjects, including smokers with a≥ 10 pack-year history …

Heart failure (HF) and chronic obstructive pulmonary disease (COPD) coincide in a
significant number of patients. Recent population-based registries suggest that spirometry is …

Patients with chronic obstructive pulmonary disease (COPD) are at increased risk of
cardiovascular disease (CVD) and concomitant disease leads to reduced quality of life …

Chronic obstructive pulmonary disease (COPD) and cardiovascular disease often coexist,
and acute cardiac events frequently occur during COPD exacerbations. Even when cardiac …